Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 23;14(4):e0215997.
doi: 10.1371/journal.pone.0215997. eCollection 2019.

Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome

Affiliations

Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome

Kristian Brat et al. PLoS One. .

Abstract

Introduction: Measurement of ventilatory efficiency, defined as minute ventilation per unit carbon dioxide production (VE/VCO2), by cardiopulmonary exercise testing (CPET) has been proposed as a screen for hyperventilation syndrome (HVS). However, increased VE/VCO2 may be associated with other disorders which need to be distinguished from HVS. A more specific marker of HVS by CPET would be clinically useful. We hypothesized ventilatory control during exercise is abnormal in patients with HVS.

Methods: Patients who underwent CPET from years 2015 through 2017 were retrospectively identified and formed the study group. HVS was defined as dyspnea with respiratory alkalosis (pH >7.45) at peak exercise with absence of acute or chronic respiratory, heart or psychiatric disease. Healthy patients were selected as controls. For comparison the Student t-test or Mann-Whitney U test were used. Data are summarized as mean ± SD or median (IQR); p<0.05 was considered significant.

Results: Twenty-nine patients with HVS were identified and 29 control subjects were selected. At rest, end-tidal carbon dioxide (PETCO2) was 27 mmHg (25-30) for HVS patients vs. 30 mmHg (28-32); in controls (p = 0.05). At peak exercise PETCO2 was also significantly lower (27 ± 4 mmHg vs. 35 ± 4 mmHg; p<0.01) and VE/VCO2 higher ((38 (35-43) vs. 31 (27-34); p<0.01)) in patients with HVS. In contrast to controls, there were minimal changes of PETCO2 (0.50 ± 5.26 mmHg vs. 6.2 ± 4.6 mmHg; p<0.01) and VE/VCO2 ((0.17 (-4.24-6.02) vs. -6.6 (-11.4-(-2.8)); p<0.01)) during exercise in patients with HVS. The absence of VE/VCO2 and PETCO2 change during exercise was specific for HVS (83% and 93%, respectively).

Conclusion: Absence of VE/VCO2 and PETCO2 change during exercise may identify patients with HVS.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Relation of VE/VCO2 and PaCO2 in patients with HVS and controls.
Slopes of ventilatory efficiency (VE/VCO2) to partial pressure of arterial oxygen (PaCO2) at peak exercise are compared in patients with HVS and controls. The shift of the slope of this relationship in patients with HVS is consistent with the observed higher VD/VT ratio (i.e. higher ventilation-perfusion mismatch).
Fig 2
Fig 2. Relation of VE/VCO2 and VD/VT in patients with HVS and controls.
Slopes of VE/VCO2 and ratio of tidal volume to dead space (VD/VT) at peak exercise are compared in patients with HVS and controls. The shift of the slope of this relationship in patients with HVS is consistent with the observed lower PaCO2 (i.e. increased ventilatory drive).
Fig 3
Fig 3. VE/VCO2 changes during exercise.
In contrast to patients with HVS, VE/VCO2 decreased during exercise in controls. ** = p<0.01 compared to rest; §§ = p<0.01 HVS vs. control.
Fig 4
Fig 4. PETCO2 changes during exercise.
In contrast to patients with HVS, PETCO2 increased during exercise in controls. ** = p<0.01 compared to rest; § = p<0.05 HVS vs. control; §§ = p<0.01 HVS vs. control.

References

    1. Malmberg LP, Tamminen K, Sovijärvi AR. Orthostatic increase of respiratory gas exchange in hyperventilation syndrome. Thorax. 2000;55: 295–301. 10.1136/thorax.55.4.295 - DOI - PMC - PubMed
    1. Chenivesse C, Similowski T, Bautin N, Fournier C, Robin S, Wallaert B, et al. Severely impaired health-related quality of life in chronic hyperventilation patients: exploratory data. Respir Med. 2014;108: 517–523. 10.1016/j.rmed.2013.10.024 - DOI - PubMed
    1. Cowley DS, Roy-Byrne PP. Hyperventilation and panic disorder. Am J Med. 1987;83: 929–937. - PubMed
    1. Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ. Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation. Am J Respir Crit Care Med. 2004;170: 118–125. 10.1164/rccm.200207-720OC - DOI - PubMed
    1. Ritz T, Meuret AE, Bhaskara L, Petersen S. Respiratory muscle tension as symptom generator in individuals with high anxiety sensitivity. Psychosom Med. 2013;75: 187–195. 10.1097/PSY.0b013e31827d1072 - DOI - PubMed

Publication types